Ozempic and Alzheimer's, 23andMe's crisis, and Novo Nordisk wants a crackdown: Pharma news roundup
qz.com › ozempic-23andme-novo-nordisk-1851680817
This story seems to be about:
This story seems to be about:
A new study found a link between NovoNordisk’s blockbuster drug Ozempic and a reduced risk of Alzheimer’s disease. 23andMe, the company that popularized consumer genetic testing, could soon be delisted from the Nasdaq. And Novo Nordisk is asking the U.S. Food and Drug Administration (FDA) to bar compounding pharmacies